Innate and adaptive mediators in cystic fibrosis and allergic fungal rhinosinusitis

American Journal of Rhinology

Volumn 21, Issue 5, 2007, Pages 538-541

  Skinner, Margaret Leigh ^a,b   Schlosser, Rodney J ^a   Lathers, Deanne ^a,c   Neal, Jeffrey G ^a   Woodworth, Bradford A ^a   Hall, Jeffrey ^a   Newton, Danforth A ^a   Baatz, John E ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Adaptive immunity; AFRS; Allergic fungal sinusitis; Cystic fibrosis; Innate immunity; Rhinosinusitis; Surfactant

Indexed keywords

EOTAXIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; ENDOSCOPIC SURGERY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INNATE IMMUNITY; MYCOSIS; NASAL BIOPSY; NOSE MUCOSA; QUANTITATIVE ANALYSIS; RHINOSINUSITIS; WESTERN BLOTTING;

CHEMOKINE CCL11; CYSTIC FIBROSIS; FUNGAL PROTEINS; GENE EXPRESSION REGULATION; HUMANS; IMMUNE SYSTEM; IMMUNITY, NATURAL; INFLAMMATION; MODELS, BIOLOGICAL; MUCOUS MEMBRANE; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RESPIRATORY MUCOSA; RHINITIS, ALLERGIC, PERENNIAL; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 36049015452     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/ajr.2007.21.3070     Document Type: Article

References (17)

1. Crouch E, Hartshorn K, and Ofek I. Collectins and pulmonary innate immunity. Immunol Rev 173:52-65, 2000.
2. Crouch E, and Wright JR. Surfactant proteins A and D and pulmonary host defense. Ann Rev Physiol 63:521-554, 2001.
3. Wright JR. Immunomodulatory functions of surfactant. Physiol Rev 77:931-962, 1997.
4. Crouch EC, Persson A, Griffin GL, et al. Interactions of pulmonary surfactant protein D with human blood leukocytes. Am J Respir Cell Mol Biol 12:410-415, 1995.
5. Pikaar JC, Voorhout WF, van Golode LMG, et al. Opsonic activities of surfactant proteins A and D in phagocytosis of gram negative bacteria by alveolar macrophages. J Infect Dis 172:481-489, 1995.
6. Ferguson JS, Voelker DR, McCormack FX, and Schlesinger LS. Surfactant protein D bind to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages. J Immunol 163:312-321, 1999.
7. Restrepo CI, Dong Q, Savov J, et al. Surfactant protein D stimulates phagocytosis of Pseudomonas aeruginaosa by alveolar macrophages. Am J Respir Cell Mol Biol 21:576-585, 1999.
8. Kishor U, Madan T, Sarma PU, et al. Protective roles of pulmonary surfactant proteins, SP-A and SP-D, against lung allergy and infection caused by Aspergillus fumigatus. Immunobiology 205:610-618, 2002.
9. Saxena S, Madan T, Shah A, et al. Association of polymorphisms in the collagen region of SP-A2 with increased levels of total IgE antibodies and eosinophilia in patients with allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 111:1001-1007, 2003.
10. Noah TL, Murphy PC, Alink JJ, et al. Bronchoalveolar lavage fluid surfactant protein-A and surfactant protein-D are inversely related to inflammation in early cystic fibrosis. Am J Respir Crit Care Med 168:685-691, 2003.
11. Postle AD, Mander A, Reid KBM, et al. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis. Am J Respir Cell Mol Biol 20:90-98, 1999.
12. Woodworth BA, Smythe N, Spicer SS, et al. Presence of surfactant lamellar bodies in normal and diseased sinus mucosa. ORL J Otorhinolaryngol Relat Spec 67:199-202, 2005.
13. Zhang L, Ikegami M, Dey CR, et al. Reversibility of pulmonary abnormalities by conditional replacement of surfactant protein D (SP D) in vivo. J Biol Chem 277:38709-38713, 2002.
14. Bent JP, and Kuhn FA. Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg 111:580-588, 1994.
15. Strong P, Reid KB, and Clark H. Intranasal delivery of a truncated recombinant human SP D is effective at down-regulating allergic hypersensitivity in mice sensitized to allergens of Aspergillus fumigatus. Clin Exp Immunol 130:19-24, 2002.
16. Hohlfeld JM, Erpenbeck VJ, and Krug N. Surfactant proteins SP-A and SP-D as modulators of the allergic inflammation in asthma. Pathobiol 70:287-292, 2002-2003. Review.
17. Wang JY, Shieh CC, You PF, et al. Inhibitory effect of pulmonary surfactant proteins A and D on allergen-induced lymphocyte proliferation and histamine release in children with asthma. Am J Respir Crit Care Med 158:510-518, 1998.